RWMG
BEAM icon

Redwood Wealth Management Group’s Beam Therapeutics BEAM Stock Holding History

Redwood Wealth Management Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-90
Closed -$2.11K – 257
2024
Q2 		$2.11K Buy
+90
New +$2.21K ﹤0.01% 892

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Redwood Wealth Management Group's BEAM Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Beam Therapeutics (BEAM) in Q3 2024, closing a stake of 90 shares — an estimated $2.11K sold.

Redwood Wealth Management Group first reported a position in BEAM in Q2 2024 and held it in 1 quarter. The position peaked at $2.11K in Q2 2024. 221 funds tracked by Wall St. Rank hold BEAM as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Beam Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 90 Beam Therapeutics shares in Q3 2024, an estimated $2.11K.
  • Redwood Wealth Management Group first reported a position in Beam Therapeutics in Q2 2024 and held it in 1 quarter.
  • Redwood Wealth Management Group's Beam Therapeutics position peaked at $2.11K in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.